Literature DB >> 12832393

A novel pseudoknot element is essential for the action of a yeast telomerase.

Yehuda Tzfati1, Zachary Knight, Jagoree Roy, Elizabeth H Blackburn.   

Abstract

Telomerase contains an essential RNA, which includes the template sequence copied by the reverse transcription action of telomerase into telomeric DNA. Using phylogenetic comparison, we identified seven conserved sequences in telomerase RNAs from Kluyveromyces budding yeasts. We show that two of these sequences, CS3 and CS4, are essential for normal telomerase function and can base-pair to form a putative long-range pseudoknot. Disrupting this base-pairing was deleterious to cell growth, telomere maintenance, and telomerase activity. Restoration of the base-pairing potential alleviated these phenotypes. Mutating this pseudoknot caused a novel mode of shifting of the boundaries of the RNA template sequence copied by telomerase. A phylogenetically derived model of yeast TER structure indicates that these RNAs can form two alternative predicted core conformations of similar stability: one brings the CS3/CS4 pseudoknot spatially close to the template; in the other, CS3 and CS4 move apart and the conformation of the template is altered. We propose that such disruption of the pseudoknot, and potentially the predicted telomerase RNA conformation, affects polymerization to cause the observed shifts in template usage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832393      PMCID: PMC196185          DOI: 10.1101/gad.1099403

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  38 in total

1.  Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle.

Authors:  A G Seto; A J Zaug; S G Sobel; S L Wolin; T R Cech
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

2.  Secondary structure of vertebrate telomerase RNA.

Authors:  J L Chen; M A Blasco; C W Greider
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

Review 3.  Telomeres and their control.

Authors:  M J McEachern; A Krauskopf; E H Blackburn
Journal:  Annu Rev Genet       Date:  2000       Impact factor: 16.830

4.  Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 5.  The end of the (DNA) line.

Authors:  E H Blackburn
Journal:  Nat Struct Biol       Date:  2000-10

6.  Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability.

Authors:  C Guiducci; M A Cerone; S Bacchetti
Journal:  Oncogene       Date:  2001-02-08       Impact factor: 9.867

7.  A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.

Authors:  M M Kim; M A Rivera; I L Botchkina; R Shalaby; A D Thor; E H Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

8.  Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system.

Authors:  L Martin-Rivera; M A Blasco
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

9.  Altering telomere structure allows telomerase to act in yeast lacking ATM kinases.

Authors:  S W Chan; J Chang; J Prescott; E H Blackburn
Journal:  Curr Biol       Date:  2001-08-21       Impact factor: 10.834

10.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.

Authors:  T Vulliamy; A Marrone; F Goldman; A Dearlove; M Bessler; P J Mason; I Dokal
Journal:  Nature       Date:  2001-09-27       Impact factor: 49.962

View more
  44 in total

Review 1.  Telomeres and telomerase.

Authors:  Simon R W L Chan; Elizabeth H Blackburn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-01-29       Impact factor: 6.237

2.  An emerging consensus for telomerase RNA structure.

Authors:  Jiunn-Liang Chen; Carol W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

Review 3.  Telomerase: an RNP enzyme synthesizes DNA.

Authors:  Elizabeth H Blackburn; Kathleen Collins
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

4.  Ku can contribute to telomere lengthening in yeast at multiple positions in the telomerase RNP.

Authors:  David C Zappulla; Karen J Goodrich; Julian R Arthur; Lisa A Gurski; Elizabeth M Denham; Anne E Stellwagen; Thomas R Cech
Journal:  RNA       Date:  2010-12-21       Impact factor: 4.942

5.  Telomerase limits the extent of base pairing between template RNA and telomeric DNA.

Authors:  Klaus Förstemann; Joachim Lingner
Journal:  EMBO Rep       Date:  2005-04       Impact factor: 8.807

6.  Biological and biochemical functions of RNA in the tetrahymena telomerase holoenzyme.

Authors:  Doreen D Cunningham; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  A triple helix within a pseudoknot is a conserved and essential element of telomerase RNA.

Authors:  Kinneret Shefer; Yogev Brown; Valentin Gorkovoy; Tamar Nussbaum; Nikolai B Ulyanov; Yehuda Tzfati
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

8.  The role of nonhomologous end-joining components in telomere metabolism in Kluyveromyces lactis.

Authors:  Sidney D Carter; Shilpa Iyer; Jianing Xu; Michael J McEachern; Stefan U Aström
Journal:  Genetics       Date:  2007-01-21       Impact factor: 4.562

9.  The tedious task of finding homologous noncoding RNA genes.

Authors:  Peter Menzel; Jan Gorodkin; Peter F Stadler
Journal:  RNA       Date:  2009-10-27       Impact factor: 4.942

10.  Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.

Authors:  Tara J Moriarty; Delphine T Marie-Egyptienne; Chantal Autexier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.